Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

4(80.0%)

Phase 4

1(20.0%)

5Total

N/A(4)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT03454373Not ApplicableCompleted

Long Term Follow-Up of Food and Cash Assistance for HIV-Positive Men and Women on Antiretroviral Therapy in Tanzania

Role: collaborator

NCT01957917Not ApplicableCompleted

Comparing Food and Cash Assistance for HIV-Positive Men and Women on Antiretroviral Therapy in Tanzania

Role: collaborator

NCT02590627Phase 4Completed

In-vivo Efficacy and Safety of Artemether/Lumefantrine Vs Dihydroartemisinin-piperaquine for Treatment of Uncomplicated Malaria and Assessment of Parasite Genetic Factors Associated With Parasite Clearance or Treatment Failure

Role: collaborator

NCT03058484Not ApplicableCompleted

Community Health Workers and Prevention of Mother-to-Child HIV Transmission in Tanzania

Role: collaborator

NCT01992887Completed

Pre-ART Retention in Care in Tanzania

Role: collaborator

NCT01746758Not ApplicableUnknown

Mobile Phone Text Messaging Referral

Role: collaborator

All 6 trials loaded